Few & Far Between: Conversations from the Front Lines of Drug Development
Chris O'Brien
35 episodes
1 week ago
Welcome to Few & Far Between! Chris O'Brien, CEO of Biorasi, is your host for Conversations from the Front Lines of Drug Development - from clinical research and policymakers to biotech innovators and industry leaders.
All content for Few & Far Between: Conversations from the Front Lines of Drug Development is the property of Chris O'Brien and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Welcome to Few & Far Between! Chris O'Brien, CEO of Biorasi, is your host for Conversations from the Front Lines of Drug Development - from clinical research and policymakers to biotech innovators and industry leaders.
Episode 49: Eileen Faucher, Principal and Founder, Brass Tacks Health
Few & Far Between: Conversations from the Front Lines of Drug Development
35 minutes 37 seconds
8 months ago
Episode 49: Eileen Faucher, Principal and Founder, Brass Tacks Health
Today on the Biorasi Few & Far Between podcast:
What if you could read a story before its official release? Competitive intelligence gives you early access to information on emerging trends in clinical trials.
On today's episode, host Chris O'Brien welcomes Eileen Faucher. Eileen is the Principal and Founder of Brass Tacks Health, a company that provides insights that biotechs need to drive clinically-meaningful therapies.
Listen in to get the ROI on competitive intelligence, concise communications, and helping patients find relevant clinical trials.
Thanks for listening!
Few & Far Between: Conversations from the Front Lines of Drug Development
Welcome to Few & Far Between! Chris O'Brien, CEO of Biorasi, is your host for Conversations from the Front Lines of Drug Development - from clinical research and policymakers to biotech innovators and industry leaders.
